Clinical Trials Directory

Trials / Completed

CompletedNCT03051425

Immune Benefits of Consumption of Dairy Yogurt in Elderly

Immune Benefits of Consumption of Dairy Yogurt Containing Functional Probiotics Among Individuals Over 60 Years Old

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

To investigate the impact of consuming dairy yogurt on immun function including natural killer (NK) cell activity, circulating levels of cytokines, and immunoglobulin (Ig) in elderly.

Detailed description

A randomized, open-labelled, placebo-controlled study was conducted on 200 nondiabetic, nonobese and elderly (≥60 years) subjects. Over a twelve-week period, the test group consumed one bottle (120 mL) of dairy yogurt each day, whereas the placebo group consumed same volume of low fat milk daily. NK cell activity (%) was measured based on the ratios of effector cells (E; peripheral blood mononuclear cells, PBMCs) from each participant to target cells (T; K562 cells) at E:T= 10:1, 5:1, 2.5:1, 1.25:1 or 0.625:1. In addition, cytokines and immunoglobulin levels measured using commercial kits as manufacturer's instruction.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbiotic yogurt120 mL of Yogurt containing Lactobacillus delbrueckii subsp. bulgaricus, Streptococcus thermophilus, Lactobacillus casei, Bifidobacterium animalis ssp. lactis, and Lactobacillus plantarum
DIETARY_SUPPLEMENTPlacebo120 mL of low-fat milk

Timeline

Start date
2016-03-28
Primary completion
2017-01-10
Completion
2017-02-08
First posted
2017-02-13
Last updated
2017-02-13

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03051425. Inclusion in this directory is not an endorsement.